Serum fibroblast growth factor 19 and endogenous islet beta cell function in type 2 diabetic patients
Abstract
Fibroblast growth factor 19 (FGF19) takes part in maintaining the balance of glycolipids and may be involved in regulating the secretory activity of islet beta cells in patients with type 2 diabetes. This study aimed to evaluate the relationship between the levels of serum FGF19 and endogenous islet beta cell function in type 2 diabetic patients.Samples were obtained from 271 subjects: 85 drug-naïve type 2 diabetes participants exclusively on...
Paper Details
Title
Serum fibroblast growth factor 19 and endogenous islet beta cell function in type 2 diabetic patients
Published Date
Sep 24, 2019
Volume
11
Issue
1
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History